No price history available.
Key financial summary
Financials in KRW| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | KRWm | 294,984 | 359,795 | 438,188 | 421,367 | 435,798 | 441,138 | N/A | N/A |
| Operating profit | KRWm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | KRWm | 51,848 | 57,743 | 72,216 | 61,016 | 50,549 | 43,522 | N/A | N/A |
| EPS reported | KRW | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | KRW | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | KRW | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | KRW | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | KRWm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | KRWm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | KRWm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | KRW | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | KRW | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in KRW| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Established in 1959 and headquartered in Anyang, South Korea, Miwon Commercial Co., Ltd. is a global producer and distributor of a broad array of chemical products. The company's offerings include a comprehensive range of personal care ingredients, such as various types of surfactants (anionic, cationic, nonionic, and amphoteric), polymers for hair conditioning and fixation, styling resins, household cleaning surfactants, plasticizers, UV stabilizers, and active ingredients for cosmeceutical applications. Miwon is also a key supplier of electronic chemicals. This segment encompasses photoactive compounds vital for micro-patterning in semiconductor circuits and thin-film transistors for LCDs; polymer acryl binders; and novolak resins, which are integral to LCD and plasma displays, as well as positive photoresists for LCDs and semiconductors. Additionally, they provide functional chemicals and additives for positive and negative photoresists in LCDs, alongside process chemicals like strippers. Their functional resins serve as fundamental materials for printed circuit boards (PCBs), electronic equipment components, high-performance polycarbonates, and high-refractive monomers utilized in manufacturing optical films for displays. Furthermore, the company's portfolio extends to a variety of antioxidants, including amine, phenol, phosphorus, and sulfur types, as well as UV stabilizers such as benzophenone, benzotriazole, nickel quenchers, and HALS. Miwon also manufactures thiourethane lens monomers.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Miwon Commercial Co., Ltd. (002840.KS)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Established in 1959 and headquartered in Anyang, South Korea, Miwon Commercial Co., Ltd. is a global producer and distributor of a broad array of chemical products. The company's offerings include a comprehensive range of personal care ingredients, such as various types of surfactants (anionic, cationic, nonionic, and amphoteric), polymers for hair conditioning and fixation, styling resins, household cleaning surfactants, plasticizers, UV stabilizers, and active ingredients for cosmeceutical applications. Miwon is also a key supplier of electronic chemicals. This segment encompasses photoactive compounds vital for micro-patterning in semiconductor circuits and thin-film transistors for LCDs; polymer acryl binders; and novolak resins, which are integral to LCD and plasma displays, as well as positive photoresists for LCDs and semiconductors. Additionally, they provide functional chemicals and additives for positive and negative photoresists in LCDs, alongside process chemicals like strippers. Their functional resins serve as fundamental materials for printed circuit boards (PCBs), electronic equipment components, high-performance polycarbonates, and high-refractive monomers utilized in manufacturing optical films for displays. Furthermore, the company's portfolio extends to a variety of antioxidants, including amine, phenol, phosphorus, and sulfur types, as well as UV stabilizers such as benzophenone, benzotriazole, nickel quenchers, and HALS. Miwon also manufactures thiourethane lens monomers.
